Symptomatic catheter related thrombosis (CRT) occurs in 4%–8% of cancer patients. The
mean incidence of CRT, detected either by echography or Doppler ranges between 12 and …

Symptomatic thromboembolic complications of central venous catheters (CVCs) occur in 5%
or less of general oncology patients. Asymptomatic CVC-related thrombi are more common …

Increased incidence of cancers and the development of totally implanted venous access
devices that contain their own port to deliver chemotherapy will lead to a greater than before …

Background Central venous catheters are essential to management of cancer patients.
Thrombotic complications are potentially severe, but it is difficult to prescribe systematically a …

Central venous catheters are extensively used in patients with cancer to secure delivery of
chemotherapy and facilitate phlebotomy. Unfortunately, considerable morbidity can result …

Venous thromboembolism (VTE) occurs frequently in patients with hemato-oncological
diseases and is one of the leading causes of death [1]. The risk for developing VTE may be …

The adequate handling of central venous catheters is a key element in the management of
patients with cancer. Catheter-associated deep vein thrombosis is frequently observed in …

Long-term central venous catheters (CVCs) have considerably improved the management of
cancer patients because they facilitate chemotherapy, transfusions, parenteral nutrition, and …

Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the mechanism of thrombosis in CVCs. Explain the symptoms, signs, and sequelae …

Background: Knowledge of independent, baseline risk factors for catheter‐related
thrombosis (CRT) may help select adult cancer patients who are at high risk to receive …